Literature DB >> 33860974

Clinical research on traditional Chinese medicine treatment for bacterial vaginosis.

Haiyue Zhao1, Lijie Zhao2, Fei Wu2, Lan Shen1.   

Abstract

Bacterial vaginosis (BV) is a common disease among women of reproductive age, with a serious impact on their daily life and health. At present, the most common treatment for BV is to take antibiotics, which results in good short-term treatment effects, but poor long-term effects. Traditional Chinese medicine (TCM) has been used to treat BV for over a millennium, with little risk of triggering drug resistance and adverse effects. Based on syndrome differentiation, there are three oral TCM treatment strategies for BV, including invigorating spleen, clearing dampness and heat, and nourishing kidney. The oral TCM prescriptions, such as Yi Huang decoction, Longdan Xiegan decoction, Zhibai Dihaung decoction, and so on are commonly used. Topical TCM treatment is also popular in China. According to the research results of pharmacological effects of active TCM ingredients, the most potential mechanisms of TCM for BV treatment are immune-enhancement effects, antibacterial activity, and estrogen-liked effects. Nonetheless, the multi-constituent of herbs may result in possible disadvantages to BV treatment, and the pharmacological mechanisms of TCM need further study. Here, we provide an overview of TCM compounds and their preparations used for BV, based on the pathogenesis and the potential therapeutic mechanisms, therefore providing a reference for further studies.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  bacterial vaginosis; clinical use; pharmacological mechanism; traditional Chinese medicine

Year:  2021        PMID: 33860974     DOI: 10.1002/ptr.7123

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  2 in total

1.  Accurate 16S Absolute Quantification Sequencing Revealed Vaginal Microecological Composition and Dynamics During Mixed Vaginitis Treatment With Fufang FuRong Effervescent Suppository.

Authors:  Meng Li; Zhen Zeng; Huijun Feng; Yang Cao; Qiongqiong Zhang; Tao Lv; Xingsheng Yang; Dianrong Song; Ping Li; Lina Hu; Shangrong Fan; Ruifang An; Bei Zhang; Lei Zhang; Qinping Liao
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

2.  Combination Therapy with TCM Preparation Kumu Injection and Azithromycin against Bacterial Infection and Inflammation: In Vitro and In Vivo.

Authors:  Meiyu Yu; Xuejing Gu; Yanzheng Qu; Fuyou Sun; Yanli Li; Feng Zhao; Hui Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-16       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.